Product Information
CHLD ACETAMINOPHEN 160 MG/5 ML is a generic product labeled by Major Pharmaceuticals, priced at $0.0241 per ML under NDC 00904701420. Its NADAC has been published 346 times since Feb 19, 2020.
Strength
160 mg/5mL
Manufacturer
Major PharmaceuticalsNDC
00904701420
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
10/1/2019
Price Statistics
The NADAC for CHLD ACETAMINOPHEN 160 MG/5 ML has been published 346 times since Feb 19, 2020, and over the history we have for it it has declined 30.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0241 per ML |
|---|---|
| All-time high | $0.0348 (Jun 10, 2020) |
| All-time low | $0.0173 (Oct 18, 2023) |
| 52-week high | $0.0331 |
| 52-week low | $0.0241 |
| Median price | $0.0236 |
| Average price | $0.0245 |
| Largest weekly change | +50.3% (Jun 19, 2024) |
| Weeks tracked | 346 |
| Tracking since | Feb 19, 2020 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 56% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHLD ACETAMINOPHEN 160 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for CHLD ACETAMINOPHEN 160 MG/5 ML, manufactured by Major Pharmaceuticals, is $0.0241 per ML (NDC 00904701420), effective Sep 30, 2026.
How has the price of CHLD ACETAMINOPHEN 160 MG/5 ML changed over time?
Over the history we have for it, the NADAC for CHLD ACETAMINOPHEN 160 MG/5 ML has declined 30.8%. It has been tracked across 346 weekly CMS publications since Feb 19, 2020.
What are the highest and lowest recorded NADAC prices for CHLD ACETAMINOPHEN 160 MG/5 ML?
Since Feb 19, 2020, the NADAC for CHLD ACETAMINOPHEN 160 MG/5 ML has ranged from a low of $0.0173 (Oct 18, 2023) to a high of $0.0348 (Jun 10, 2020), with a median of $0.0236 per ML.
Are there cheaper alternatives to CHLD ACETAMINOPHEN 160 MG/5 ML?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHLD ACETAMINOPHEN 160 MG/5 ML, is $0.0107 per ML — about 56% below CHLD ACETAMINOPHEN 160 MG/5 ML.
Who manufactures CHLD ACETAMINOPHEN 160 MG/5 ML?
CHLD ACETAMINOPHEN 160 MG/5 ML (NDC 00904701420) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.